Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Stellaromics
Stellaromics

Stellaromics

Series A

Stellaromics, a Natick-based software company, specializes in 3D multi-omic analysis technology.

HQ
Natick, MA, US
Founded
2022
Overview
Compare
Fundraising
Employees

Stellaromics, founded in Natick, Massachusetts, is a biotechnology company dedicated to advancing biomedical research through its cutting-edge 3D in situ multi-omic analysis technology. The company's core mission is to empower researchers and clinicians by providing high-resolution, spatially preserved gene expression data from thick tissue samples. This innovative approach aims to revolutionize the understanding of complex biological systems and disease mechanisms, with a focus on enhancing precision medicine and therapeutic development.

Stellaromics has garnered significant attention and investment, securing $25 million in Series A funding. The company is led by a team of experts in biotechnology and software development, whose combined expertise drives its technological advancements. Stellaromics' achievements include developing one of the most powerful tools for 3D multi-omic analysis, which has the potential to make a substantial impact on biomedical research and healthcare. By enabling more detailed and accurate tissue analysis, Stellaromics is poised to contribute significantly to the future of personalized medicine.

Stellaromics - Similar Companies

Aperture Bio logo

Aperture Bio

aperture.bio

Via Scientific logo

Via Scientific

viascientific.com

Omix.ai logo

Omix.ai

Newomics logo

Newomics

newomics.com

Octant logo

Octant

octant.bio

NantOmics logo

NantOmics

nantomics.com

OmicsChart logo

OmicsChart

omicschart.com

Triomics logo

Triomics

triomics.com

NKA Bio logo

NKA Bio

nkabio.com

Biotechonomy logo

Biotechonomy

Cellanome logo

Cellanome

cellanome.com

AtlasXomics logo

AtlasXomics

atlasxomics.com

Larkspur Biosciences logo

Larkspur Biosciences

larkspur.bio

Stellate DNA logo

Stellate DNA

stellatedna.com

Galatea Bio logo

Galatea Bio

galatea.bio

Stellaromics - Quick Facts

Who are Stellaromics' competitors?

Companies similar to Stellaromics include Aperture Bio, Via Scientific, Omix.ai and Newomics.

When was Stellaromics founded?

Stellaromics was founded in 2022.

Where is Stellaromics' headquarters located?

Stellaromics' headquarters is located in Natick, MA, US.

When was Stellaromics' last funding round?

Stellaromics' most recent funding round was for $25M (USD) in November 2023.

How much has Stellaromics raised to-date?

As of Nov 2, 2023, Stellaromics has raised a total of $25M (USD).

How many employees does Stellaromics have?

Stellaromics has 6 employees as of Feb 4, 2024.

Stellaromics - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biotech Software
Tags
  • Biotech
  • Data
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software